Annual Accounts Payable
$2.08 M
-$505.00 K-19.55%
December 31, 2021
Summary
- As of February 10, 2025, SBTX annual accounts payable is $2.08 million, with the most recent change of -$505.00 thousand (-19.55%) on December 31, 2021.
- During the last 3 years, SBTX annual accounts payable has risen by +$1.30 million (+168.13%).
Performance
SBTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$126.00 K
-$1.99 M-94.04%
September 30, 2022
Summary
- As of February 10, 2025, SBTX quarterly accounts payable is $126.00 thousand, with the most recent change of -$1.99 million (-94.04%) on September 30, 2022.
- Over the past year, SBTX quarterly accounts payable has dropped by -$1.59 million (-92.67%).
Performance
SBTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SBTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.6% | -92.7% |
| 3 y3 years | +168.1% | -96.4% |
| 5 y5 years | +168.1% | -96.4% |
SBTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -95.2% | at low |
| 5 y | 5-year | -40.9% | at low | -97.1% | at low |
| alltime | all time | -40.9% | -62.7% | -97.1% | at low |
Silverback Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $126.00 K(-94.0%) |
| Jun 2022 | - | $2.11 M(-19.7%) |
| Mar 2022 | - | $2.63 M(+26.6%) |
| Dec 2021 | $2.08 M | $2.08 M(+20.8%) |
| Sep 2021 | - | $1.72 M(-4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $1.80 M(-58.7%) |
| Mar 2021 | - | $4.37 M(+69.3%) |
| Dec 2020 | $2.58 M(-26.6%) | $2.58 M(+19.7%) |
| Sep 2020 | - | $2.16 M(-38.7%) |
| Dec 2019 | $3.52 M(+353.9%) | $3.52 M |
| Dec 2018 | $775.00 K | - |
FAQ
- What is Silverback Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Silverback Therapeutics?
- What is Silverback Therapeutics annual accounts payable year-on-year change?
- What is Silverback Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Silverback Therapeutics?
- What is Silverback Therapeutics quarterly accounts payable year-on-year change?
What is Silverback Therapeutics annual accounts payable?
The current annual accounts payable of SBTX is $2.08 M
What is the all time high annual accounts payable for Silverback Therapeutics?
Silverback Therapeutics all-time high annual accounts payable is $3.52 M
What is Silverback Therapeutics annual accounts payable year-on-year change?
Over the past year, SBTX annual accounts payable has changed by -$505.00 K (-19.55%)
What is Silverback Therapeutics quarterly accounts payable?
The current quarterly accounts payable of SBTX is $126.00 K
What is the all time high quarterly accounts payable for Silverback Therapeutics?
Silverback Therapeutics all-time high quarterly accounts payable is $4.37 M
What is Silverback Therapeutics quarterly accounts payable year-on-year change?
Over the past year, SBTX quarterly accounts payable has changed by -$1.59 M (-92.67%)